Elsevier Announces its Collaboration with Turkish Academic Network and Information Center

ANKARA, Turkey, July 1, 2013 /PRNewswire/ --

 

177 universities in Turkey benefit from access to Scopus and ScienceDirect for the next 3 years


Elsevier, a world-leading provider of scientific, technical, and medical information products and services, today announced its agreement with the Turkish Academic Network and Information Center (ULAKBIM) to provide 177 academic and research institutions in Turkey with access to Scopus, the largest abstract and citation database of peer-reviewed literature. In addition, access to ScienceDirect, Elsevier's full-text platform for research literature has been extended.

The 3-year agreement ensures Turkish researchers can benefit from access to high quality, world-class scholarly information resources and tools, allowing them to stay abreast of scientific developments in their fields. The previous ScienceDirect agreement with ULAKBIM provided access to 104 institutions, whereas the new agreement welcomes an additional 73 new members.

Dr. Ahmet Kaplan, Acting Director of ULAKBIM, said, "At ULAKBIM, we aim to provide our researchers with top quality scholarly information resources. Securing access to Scopus and ScienceDirect enables us to offer Turkish scientists the opportunity to broaden their global academic network and advance their research output. Our collaboration with Elsevier helps us to reach our objectives."

Tayfun Basal, Elsevier Regional Director for Turkey, Middle East and Central Asia, said, "We are pleased to see Scopus is now under national license in Turkey, similar to ScienceDirect. Access to these solutions will help Turkish scientists improve their reach within the global academic community. ULAKBIM's main goal is to provide access to scholarly information to help advance Turkey's scientific position. We are honored to support ULAKBIM in achieving this goal."

# # #

About Turkish Academic Network and Information Center (ULAKBIM), Turkey

The Turkish Academic Network and Information Centre (ULAKBIM) was founded as a R&D Facility Institute of TÜBÝTAK(*) in 1996. ULAKBIM's main objectives have been set as operating a high speed computer network enabling interaction within the institutional elements of the national innovation system, and providing information technology support and information services to help scientific production. ULAKBIM aims at providing technological facilities such as computer networks, information technology support, and information and document delivery services, to meet the information requirements of universities and research institutions, and to increase the efficiency and productivity of their end users. ULAKBIM consists of National Academic Network (ULAKNET) Unit, which undertakes the task of formation and operation of research and education network infrastructure in Turkey, and CahitArf Information Center, which provides information and document supply services nationwide.

 (*)TÜBÝTAK: The Scientific and Technological Research Council of Turkey

About ScienceDirect

ScienceDirect is a world premier full-text scientific database offering journal articles and book chapters from more than 2,500 peer-reviewed journals and 11,000 books. The platform offers search and retrieval functionalities that enable users to work effectively in the knowledge discovery process. ScienceDirect aims to revolutionize the traditional format of the academic paper; interactive elements, enhanced online-readability, alerting services, and linking options to external datasets help researchers to build insights at the article level. ScienceDirect now has more than 10 million users; its wide reach makes it an ideal place for scientists to publish and disseminate their research findings.

About Scopus

Scopus, the largest abstract and citation database of peer-reviewed literature, features smart tools to track, analyze and visualize scholarly research. Its vast database contains abstracts and references from nearly 21,000 titles from 5,000 publishers worldwide, ensuring broad interdisciplinary coverage in the fields of science, technology, medicine, social sciences and Arts & Humanities. Scopus was designed and developed with input from researchers and librarians internationally; and features direct links to subscribed full-text articles, other library resources and interoperability with applications such as reference management software.

About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.

Media contact

Gamze Keskin

Elsevier, Turkey, Iran, Middle East and Central Asia

+90-533-330-57-99,
g.keskin@elsevier.com


SOURCE Elsevier



More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.